Rheumatic Disease
Virtual Grand Rounds
Update on Psoriatic Arthritis—Perspectives From the Dermatology–Rheumatology Experience
Release Date: November 29, 2011
Expiration Date: November 29, 2012
Estimated Time of Completion: 30 minutes
Description
The purpose of this activity is to provide an update on management strategies for patients with psoriatic arthritis (PsA) and describe the benefit of collaboration between rheumatology and dermatology.
Learning Objectives
- Outline the cutaneous and musculoskeletal features of PsA.
- Describe available classification criteria and methodology to assist in making a diagnosis of PsA.
- Identify and manage comorbidities in patients with PsA.
- Describe the beneficial aspects of optimizing interdisciplinary exchanges in the care of the patient with PsA.
Target Audience
This activity is intended for rheumatologists, primary care physicians, and other clinicians who treat patients with rheumatic diseases, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), gout, systemic lupus erythematosus (SLE), and antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV).
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
RJ Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Faculty
M. Elaine Husni, MD, MPH
Assistant Professor
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Vice Chair of Rheumatology and Director
Arthritis and Musculoskeletal Center
Cleveland Clinic
Cleveland, Ohio
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Leonard Calabrese, DO |
||
| Amgen Inc.; Bristol-Myers Squibb Company; Centocor, Inc.; Pfizer Inc.; Roche-Genentech |
Consulting | |
| Amgen Inc.; Bristol-Myers Squibb Company; Centocor, Inc.; Pfizer Inc.; Roche-Genentech |
Teaching and Speaking | |
The following faculty has indicated that she has no relationship which, in the context of her presentation, could be perceived as potential conflict of interest:
M. Elaine Husni, MD, MPH
The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from:
Abbott Laboratories
Genentech, Inc.
This CME activity was produced by the
Cleveland Clinic Foundation
Center for Continuing Education and
![]()







